Regenerative Medicine in the News...
Surgical Adhesive Technology Receives FDA Panel Recommendation
TissuGlu®—University of Pittsburgh-developed surgical adhesive technology—received a positive recommendation from a U.S. Food and Drug Administration panel for the approximation of tissue layers where subcutaneous dead space exists between tissue planes in large flap surgical procedures such as abdominoplasty. If approved, TissuGlu® will be the first internal surgical adhesive of its kind approved for large flap surgeries in the United States.
Dr. Rocky Tuan Appointed Distinguished Professor of Orthopaedic Surgery
McGowan Institute for Regenerative Medicine Associate Director Rocky Tuan, PhD, has been appointed Distinguished Professor of Orthopaedic Surgery in the University of Pittsburgh School of Medicine effective September 1, 2014.
From Stem Cells, New Roots
Using a method called revascularization, dentists—including McGowan Institute for Regenerative Medicine affiliated faculty member Herbert Ray, DMD—are bringing new life to dead permanent teeth by stimulating the rich supply of stem cells that live in a tooth’s root, particularly in the teeth of children.
Video: Introduction to the McGowan Institute for Regenerative Medicine
Need an introduction to what exactly we do at the McGowan Institute? Here is a video that highlights some of our research and scientists.